Catalent invests $5m at its Somerset, US site

The investment will see the site focus on preclinical to clinical phase IIb formulation, analytical and manufacturing solutions for orally delivered small molecules

picture of

Breaking News

Catalent completes $5.5m phased clinical storage expansion

The global specialist for providing advanced delivery technologies and development solutions for drugs, biologics and ...

Cell and Gene Therapy Catapult announces major UK investment in skills and capabilities

£3 million in Government investment to drive forward the Life Sciences Industrial Strategy via apprenticeships and ...

Life Sciences sector responds to report on the impact of Brexit

The Business, Energy and Indsutrial Strategy (BEIS) Committee report calls on the Government to secure a post-Brexit ...

Should robots pay taxes?

Robot tax? A tax on robotics is as absurd an idea as a tax on pencils

New therapeutic target for rheumatoid arthritis

University of Birmingham Enterprise announces the formation of a new spinout company, Viatem Ltd, to develop and ...

Catalent Biologics and Valerius Biopharma to collaborate

The partnership will aim to develop and expand manufacture of Valerius’ biosimilar products

A look back at 2017 healthcare transactions

Last year, 2017, saw 2011 deals complete, with Q2 showing the strongest performance with 29.4%, followed by Q1 with 27. ...

Ardena acquires Syntagon

Contract development and manufacturing organisation acquires a specialist contract manufacturer of novel active ...

“There's a huge need for medication specifically approved for FXS treatment”

Tetra’s fragile X syndrome drug must demonstrate significant therapeutic benefits to secure market share, says ...

Slow and steady

Generic drugs find a growing position in the US pharma market

When renting might be the better option

Capital expenditure and investment in a water infrastructure are critical to maintaining an ongoing high quality ...

Synpromics receives £1.9m grant from Scottish Enterprise

The funds will expand Synpromics’ R&D programmes in gene regulation for cell and gene medicines

Cancer Research UK launches Brain Tumour Awards

The aim of the awards is to help advance understanding about the biology of the disease and the challenges translating ...